Ophthalmology

Age-related macular degeneration (AMD) and impaired vision were found to be associated with choriocapillaris flow signal deficits in patients 60 years and older.

Eyes of patients with pseudophakic cystoid macular edema demonstrated greater retinal nerve fiber layer (RNFL) thickness compared with healthy eyes.

In a real-world setting, artificial intelligence (AI) proved to be effective in screening for referable diabetic retinopathy.

Researchers also suggest potential new genetic associations with macular edema, which warrant further research.

Although major gender bias on the national level was not found, differences in medical knowledge (MK) ratings could be an indicator of gender bias in ophthalmology education.

Higher-cost therapies for age-related macular edema (ARMD) were significantly more likely to be prescribed by ophthalmologists accepting manufacturer payments.

Severe and frequent ocular symptoms were more likely in adolescents and young adults who used e-cigarettes and cigarettes.

Recurrent exudations in patients with exudative age-related macular degeneration (eAMD) can be sufficiently monitored with macular thickness maps alone.

The FDA approved a higher dosage of aflibercept (Eylea) for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy.

Individuals with a higher risk of primary open-angle glaucoma (POAG) could be identified using a polygenic risk score, recent study found.

A recent study found that children who had private insurance had a higher probability of vision testing compared with uninsured and publicly insured children.

Patients with nonischemic branch retinal vein occlusion had their macular edema severity associated with leakage index.

The FDA approved the usage of Izervay (avacincaptad pegol) for the treatment of geographic atrophy secondary to age-related macular degeneration.

In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.

Adults who used smokeless tobacco products were more likely to have age-related macular degeneration (AMD) compared with cigarette smokers.

A study conducted in Japan found that short-term exposure to statins was not associated with an increased risk of open-angle glaucoma (OAG) in a population with dyslipidemia.

Having optometrists perform laser eye surgery was not found to lead to a meaningful increase in nearby health care professionals for the population.

Patients with age-related macular degeneration (ARMD) with geographic atrophy should use low vision aids.

A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression.

A search of residency programs in the United States found that women made up about a quarter of all academic vitreoretinal specialists.

A smartphone app was found to be useful and reliable by clinicians when testing vision for children during the COVID-19 pandemic.

Infants who received parenteral nutrition for at least 14 days had a higher risk of retinopathy of prematurity and receiving treatment.

A new study estimated that 9.60 million people are living with diabetic retinopathy and 1.84 million people are living with vision-threatening diabetic retinopathy in the United States.

Gene therapy is only one exciting area of treatments in the pipeline to potentially treat inherited retinal disease, said Byron L. Lam, MD, professor of ophthalmology, University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.

Social risk factors, such as patient characteristics and where they live, informed the severity of microbial keratitis in a sample of patients.

Fundus photographs of eyes with diabetic macular edema (DME) could be used to estimate best-corrected visual acuity (BCVA) when artificial intelligence examines the pictures.

The most exciting treatment for inherited retinal disease was approved in 2017, but there are many novel treatments in phase 2 or phase 3 trials at this point, said Byron L. Lam, MD, professor of ophthalmology, University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.

Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study.

Adalimumab had a slight advantage over infliximab in terms of adverse events when used to treat patients with noninfectious uveitis (NIU).

Insurance is by far the most important factor of whether patients followed up with treatment after getting screened for glaucoma, said Byron L. Lam, MD, professor of ophthalmology, University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.